RT @gbiondizoccai: Anyone surprised that #hydroxychloroquine is not useful as a preventive strategy againts #Covid_19? I guess not... Anyho…
132 participants (median age, 33 years [range, 20-66 years]. There was no significant difference in infection rates in participants randomized to receive hydroxychloroquine compared with placebo (4 of 64 [6.3%] vs 4 of 61 [6.6%]; P > .99) https://t.co/Q
What difference is this powered to detect? In time this will be a textbook example of how not to do studies. Amazed this got into JAMA.
RT @gbiondizoccai: Anyone surprised that #hydroxychloroquine is not useful as a preventive strategy againts #Covid_19? I guess not... Anyho…
RT @MJR_5555: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.c…
RT @gkierzek: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care...Bon, en prév…
RT @mellziland: Mais dados para se somar a MUITOS dados mostrando que a hidroxicloroquina não funciona
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @CrestaniFilho: Poucas coisas são tão certas na medicina quanto a ausência de benefícios da Cloroquina na COVID-19, já é nível de evidên…
RT @OJBoyau: Et encore une étude. Donc HCQ ça fonctionne pas en prophylaxie, en précoce, en tardif, associé ou non à AZT. Et avec plus d'ef…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @BenjaminAbella: First published pre-exposure prophylaxis for #COVID19 using #hydroxychloroquine now published in @JAMAInternalMed - tha…
RT @ABsteward: NEW 🔥🔥@JAMAInternalMed Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among He…
RT @OJBoyau: Et encore une étude. Donc HCQ ça fonctionne pas en prophylaxie, en précoce, en tardif, associé ou non à AZT. Et avec plus d'ef…
RT @DETLEFSENPatri1: Essai randomisé, pas d’efficacité de l’Hydroxychloroquine en prophylaxie! https://t.co/MnHYjT4bBY
RT @DrGrumble: No clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis in hospital-based HCWs…
RT @Health_HIV2030: Clinical trial found that a daily regimen of #Hydroxychloroquine did not prevent Health Workers from #COVID19 https://t…
Autre source intéressante très tôt lucide sur le #lancetgate, qui reste un excellent test de crédibilité dans la lecture des publications scientifiques : https://t.co/s5aXXXKbC1
Clinical trial found that a daily regimen of #Hydroxychloroquine did not prevent Health Workers from #COVID19 https://t.co/viMsFrMe9I #COVID19Ireland @Concern @COREGroupDC @DCUSNPCH @CGHTrinity @WeNurses @womeninGH @INMO_IRL @MicrobesInfect @RCSI_Irl @Doch
RT @gkierzek: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care...Bon, en prév…
No clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis in hospital-based HCWs exposed to patients with COVID-19. https://t.co/JgNQ4pqGuF
@phl43 just yesterday a *new* pre-exposure prophylaxis RCT was published; no effect (6.3% infection rate vs. 6.6% with placebo) so we can do this all over again 🙃https://t.co/xKsukY4U6Y
RT @gkierzek: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care...Bon, en prév…
RT @centinel5051: Nuevo estudio: sin eficacia de la hidroxicloroquina para prevenir infecciones por coronavirus https://t.co/Xuw7eyU2Ug
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @CrestaniFilho: Poucas coisas são tão certas na medicina quanto a ausência de benefícios da Cloroquina na COVID-19, já é nível de evidên…
RT @jameshamblin: Another clinical trial of hydroxychloroquine shows no benefit over placebo https://t.co/VsqZC40UqC
RT @MathieuMolimard: Une étude randomisée contrôlée contre placebo supplémentaire https://t.co/IpRx73bSxW Pas de protection par #hydroxy…
RT @ABsteward: NEW 🔥🔥@JAMAInternalMed Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among He…
RT @FarmaMadridAP: (JAMA) Hidroxicloroquina en profilaxis pre-exposición entre los trabajadores de la salud de los hospitales: no previno l…
Another fail by @realDonaldTrump https://t.co/glb9ulZ4NL
RT @FriedbergEric: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers:…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @FarmaMadridAP: (JAMA) Hidroxicloroquina en profilaxis pre-exposición entre los trabajadores de la salud de los hospitales: no previno l…
RT @mvholmes: Here's @_MiguelHernan 's analysis of HCQ as Covid19 prophylaxis updated with yesterday's trial (Abella et al https://t.co/mry…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @FarmaMadridAP: (JAMA) Hidroxicloroquina en profilaxis pre-exposición entre los trabajadores de la salud de los hospitales: no previno l…
RT @docanoopmisra: Prophylaxis with #HCQ fails: In this randomized clinical trial, although limited by early termination, there was no clin…
RT @CrestaniFilho: Poucas coisas são tão certas na medicina quanto a ausência de benefícios da Cloroquina na COVID-19, já é nível de evidên…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @CrestaniFilho: Poucas coisas são tão certas na medicina quanto a ausência de benefícios da Cloroquina na COVID-19, já é nível de evidên…
RT @StephaneG05: No clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis but adverse events mo…
RT @zartjr: Mais um artigo mostrando que HCQ não previne covid.
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial | Infectious Diseases | JAMA Internal Medicine | JAMA Network https://t.co/ttI1ABcy6h
RT @ABsteward: NEW 🔥🔥@JAMAInternalMed Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among He…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @ABsteward: NEW 🔥🔥@JAMAInternalMed Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among He…
RT @FarmaMadridAP: (JAMA) Hidroxicloroquina en profilaxis pre-exposición entre los trabajadores de la salud de los hospitales: no previno l…
RT @CrestaniFilho: Poucas coisas são tão certas na medicina quanto a ausência de benefícios da Cloroquina na COVID-19, já é nível de evidên…
RT @CrestaniFilho: Poucas coisas são tão certas na medicina quanto a ausência de benefícios da Cloroquina na COVID-19, já é nível de evidên…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
RT @FarmaMadridAP: (JAMA) Hidroxicloroquina en profilaxis pre-exposición entre los trabajadores de la salud de los hospitales: no previno l…
1/ Great work out of @Penn @PennMedicine @UPennEM @PennMedEVDCSO @BenjaminAbella et al publishing in @JAMAInternalMed on the role of #Hydroxychloroquine as pre-exposure prophylaxis for #COVID19 @AmaravadiRavi @Barbara_Biney @ElianaJolkovsky
RT @MathieuMolimard: Une étude randomisée contrôlée contre placebo supplémentaire https://t.co/IpRx73bSxW Pas de protection par #hydroxy…
RT @MathieuMolimard: Une étude randomisée contrôlée contre placebo supplémentaire https://t.co/IpRx73bSxW Pas de protection par #hydroxy…
RT @StephaneG05: No clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis but adverse events mo…
RT @BenjaminAbella: First published pre-exposure prophylaxis for #COVID19 using #hydroxychloroquine now published in @JAMAInternalMed - tha…
JAMA again supplies an example of weasel wording for noninformative data & why we need to drop traditional stat descriptions - https://t.co/0kKWPrx3u7 "MAY have been underpowered"?? Note the paucity of CIs and no wonder, eg one 95% CI for the odds rati
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @WesElyMD: Have you ever seen 👀 this before? JAMA on Hydroxychloroquine…The P-value here is GREATER THAN 0.99. Ahem, this stuff doesn’…
RT @BenjaminAbella: First published pre-exposure prophylaxis for #COVID19 using #hydroxychloroquine now published in @JAMAInternalMed - tha…
👇👇👇👇👇
@_nfrossi @josegallucci @TaschnerNatalia @JAMAInternalMed @JAMANetwork Por outro lado, no post inicial, há referência de estudo mais robusto (double-blind, placebo-controlled randomized clinical trial), além de ~já ter passado pelo processo de peer review~
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @StephaneG05: No clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis but adverse events mo…
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/CaD1uiENqm via @JAMAInternalMed part of @JAMANetwork
RT @ABsteward: NEW 🔥🔥@JAMAInternalMed Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among He…
RT @mellziland: Mais dados para se somar a MUITOS dados mostrando que a hidroxicloroquina não funciona
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
@ThinkActTank @pash22 @abledoc @giridar100 @prat1112001 @richardursomd has given some bytes https://t.co/ZZw06qr0XP
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
Pre-exposure prophylaxis with hydroxychloroquine fails to prevent #COVID19 in healthcare workers https://t.co/0Gf1XmMJ9P via @JAMAInternalMed part of @JAMANetwork
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @GIPEIT: ¿HCQ como profilaxis? Tampoco funciona.
RT @MathieuMolimard: Une étude randomisée contrôlée contre placebo supplémentaire https://t.co/IpRx73bSxW Pas de protection par #hydroxy…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
@markbishopuk @PeterHorby A new, small, Prophylaxis RCT result found no benefit - published yesterday: https://t.co/GwqcGgJ6w0
RT @MJA_Editor: Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/YbF0FaxbrG via @JAM…
RT @ThinkActTank: Can someone please break down this paper for me (keeping in mind the previous evidence). Haven’t followed this drug too c…
RT @ThinkActTank: Can someone please break down this paper for me (keeping in mind the previous evidence). Haven’t followed this drug too c…
RT @ThinkActTank: Can someone please break down this paper for me (keeping in mind the previous evidence). Haven’t followed this drug too c…
Can someone please break down this paper for me (keeping in mind the previous evidence). Haven’t followed this drug too closely so don’t want to miss anything important - @pash22 @abledoc @giridar100 @Dharmen46587056 @prat1112001 https://t.co/ODA4rC4IGV
RT @MathieuMolimard: Une étude randomisée contrôlée contre placebo supplémentaire https://t.co/IpRx73bSxW Pas de protection par #hydroxy…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
@claudiotognolli É um picareta esse Bolsonaro. O cara insiste numa substância q, segundo as pesquisas, não se mostrou eficiente no combate à covid-19. E ontem saiu mais uma mostrando a ñ efetividade da HCQ contra covid Aqui o original em inglês https://t.
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @jameshamblin: Another clinical trial of hydroxychloroquine shows no benefit over placebo https://t.co/VsqZC40UqC
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/IhzhcyC8F2 a través de @JAMAInternalMed part of @JAMANetwork
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
RT @SagittariusHH: HCQ fin de partie, épisode 36
@jaketapper the statement that hydroxychloroquine prevents COVID19? Our RCT just published suggests this is not supported by the science: https://t.co/b7xXMWSXCw